Depression

Get Email Updates

Resource Centers

Related Checklists

Depression Guide

Daisy Nodal Guide

Have a question? We're here to help. Ask the Community.

ASK

Free Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER!

Vyvnase may Help Patients with Depression

By Shamir Benji HERWriter December 9, 2011 - 10:06am
 
Rate This
1 comments View Comments

Depression affects millions of people. The disorder can create havoc in the individual and everyone around them. While there are effective drug treatments, many have undesirable side effects. In addition, for some unknown reason the conventional antidepressants gradually stop working. Therefore, pharmaceutical companies are continuously developing newer and better drugs. (1)

Now there is a report from a phase ll clinical study that the stimulant drug (Vyvnase) used to treat attention deficit hyperactive disorder, may help improve cognitive function in adults with depression.

Vyvnase (lisdexamfetamine dimesylate) is currently approved by the FDA for use in adults and children with ADHD.

The recent study conducted by the manufacturer of the drug showed that some patients achieved partial or full remission of depression symptoms and improved cognitive function when Vyvnase was added to their daily treatment regimen.

The specific results of the 36-patient study have not been released but summary of the study indicates that the drug was significantly superior to placebo. The randomized study ran for nine weeks. The dose of Vyvnase ranged from 20 to 70 mg per day over the first six weeks. Following this the optimal dose was continued for three more weeks.

Only four patients dropped out of the drug study because of adverse effects. The four events that led to the four people dropping out include loss of consciousness, skin rash, suicidal ideations and worsening of depression.

Other side effects of Vyvnase include diminished appetite, trouble sleeping, profuse sweating and lethargy.

The company has now submitted its results for an expanded study and hopefully will seek approval by the FDA for treatment of depression.

For the consumer this is good news but one should always be cautious about new drugs. In my opinion when companies perform their own studies, the results are usually positive and negative results are usually hidden. In addition, the study only lasted nine weeks and it is not known if the positive cognitive function is sustained. Vyvnase is also relatively expensive with each pill costing anywhere from $3-4.

 
Rate This
1 comments View Comments

We value and respect the experiences of all of our HERWriters, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice although we hope you can gain knowledge from their insight.

Around the Web

Tags

Add a Comment1 Comments

bbnrse

I would like to know what effects this drug has on people who suffer from ADHD and Depression. I suffer from major depression and ADD. I have been on dozens of antidepressants, which eventually lose their effectiveness and I have to go on another one. I hate this circus of drugs and would like to know if any company is working on something that will remain effective more than two years. I have tried many times to stop the medications over the years but have always become very suicidal and had to be admitted to the hospital. I have also received shock treatments which left me with memory problems. I look forward to a new medication, but agree that companies that do their own studies are inaccurate in their conclusions.

December 16, 2011 - 9:33am
Image CAPTCHA
By hitting submit, you agree to EmpowHER's terms of service and privacy policy

Improved

620 Health

Changed

294 Lives

Saved

210 Lives
2 lives impacted in the last 24 hrs Learn More

Health Theater Videos

View More Videos

Take our Featured Poll

Have you ever used an online community or social network to self-diagnose a medical problem?:
View Results